Sommaire

• Special Article

  • ·Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action

    Page :265-273

    Angela C. Bradshaw, J. Georges, Alzheimer Europe Board

    Résumé Résumé Plan Plan

• Original Research

  • ·Ethical Considerations at the Intersection of Social Media and Dementia Prevention Research

    Page :274-284

    V. Hrincu, G. Zaleski, J.M. Robillard

    Résumé Résumé Plan Plan   
  • ·Alzheimer’s Disease Biomarker Decision-Making among Patients with Mild Cognitive Impairment and Their Care Partners

    Page :285-293

    Chelsea G. Cox, C.R. Salazar, A.I. Birnbaum, M. Witbracht, S.P. Tam, G.T. Thai, S.A. Sajjadi, D.L. Gillen, J.D. Grill

    Résumé Résumé Plan Plan  

• Brief Communication

  • ·A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants

    Page :294-302

    C.M. Erickson, J. Karlawish, J.D. Grill, K. Harkins, S.M. Landau, M.G. Rivera-Mindt, O. Okonkwo, R.C. Petersen, P.S. Aisen, M.W. Weiner, Emily A. Largent

    Résumé Résumé Plan Plan  

• Original Research

  • ·Health Economic Considerations in the Deployment of an Alzheimer’s Prevention Therapy

    Page :303-309

    Soeren Mattke, H. Jun, M. Hanson, S. Chu, J.H. Kordower, E.M. Reiman

    Résumé Résumé Plan Plan   
  • ·Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Estimates from Real-World Data

    Page :310-319

    J. Chandler, N. Done, Urvi Desai, M. Georgieva, A. Gomez-Lievano, W. Ye, A. Zhao, D. Eid, A. Hilts, N. Kirson, T. Schilling, Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   
  • ·Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Findings from a Longitudinal Cohort Analysis

    Page :320-328

    J. Chandler, M. Georgieva, Urvi Desai, N. Done, A. Gomez-Lievano, W. Ye, A. Zhao, D. Eid, A. Hilts, N. Kirson, T. Schilling

    Résumé Résumé Plan Plan   

• Special Article

  • ·Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project

    Page :329-338

    K. Malzbender, P. Barbarino, P. Barkman Ferrell, A. Bradshaw, A.J. Brookes, C. Díaz, W.M. van der Flier, J. Georges, O. Hansson, M. Hartmanis, L. Jönsson, R. Krishnan, T. MacLeod, F. Mangialasche, P. Mecocci, C. Minguillon, L. Middleton, S. Pla, S.P. Sardi, M. Schöll, M. Suárez-Calvet, W. Weidner, P.J. Visser, H. Zetterberg, N. Bose, A. Solomon, Miia Kivipelto, AD-RIDDLE Consortium

    Résumé Résumé Plan Plan   

• Original Research

  • ·Exploring the Association between Amyloid-β and Memory Markers for Alzheimer’s Disease in Cognitively Unimpaired Older Adults

    Page :339-347

    Mario A. Parra, Y. Gazes, C. Habeck, Y. Stern

    Résumé Résumé Plan Plan   
  • ·Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men – Secondary Analysis of the AgeWell.de-trial

    Page :348-355

    Felix G. Wittmann, A. Pabst, A. Zülke, M. Luppa, I. Blotenberg, M.I. Cardona, A. Bauer, S. Fuchs, I. Zöllinger, L. Sanftenberg, C. Brettschneider, J. Döhring, L. Lunden, D. Czock, B. Wiese, J.R. Thyrian, W. Hoffmann, T. Frese, J. Gensichen, H.-H. König, H. Kaduszkiewicz, S.G. Riedel-Heller

    Résumé Résumé Plan Plan
  • ·Roles of Baseline Intrinsic Capacity and its Subdomains on the Overall Efficacy of Multidomain Intervention in Promoting Healthy Aging among Community-Dwelling Older Adults: Analysis from a Nationwide Cluster-Randomized Controlled Trial

    Page :356-365

    C.-K. Liang, W.-J. Lee, M.-Y. Chou, A.-C. Hwang, C.-S. Lin, L.-N. Peng, F.-Y. Hsiao, C.-H. Loh, Liang-Kung Chen

    Résumé Résumé Plan Plan   
  • ·A Phase 1 Single-Ascending-Dose Trial in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravenous PNT001, a Novel Mid-domain Tau Antibody Targeting cis-pT231 Tau

    Page :366-374

    Wendy Luca, K. Foster, K. McClure, M.K. Ahlijanian, M. Jefson

    Résumé Résumé Plan Plan  
  • ·Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study

    Page :375-381

    Alessandro Padovani, S. Caratozzolo, A. Benussi, A. Galli, L. Rozzini, M. Cosseddu, R. Turrone, A. Pilotto

    Résumé Résumé Plan Plan   
  • ·A Cholecystokinin Analogue Ameliorates Cognitive Deficits and Regulates Mitochondrial Dynamics via the AMPK/Drp1 Pathway in APP/PS1 Mice

    Page :382-401

    L. Hao, M. Shi, J. Ma, S. Shao, Y. Yuan, J. Liu, Z. Yu, Zhenqiang Zhang, Christian Hölscher, Zijuan Zhang

    Résumé Résumé Plan Plan  

• Review

  • ·Cost-Effectiveness of Prevention for People at Risk for Dementia: A Scoping Review and Qualitative Synthesis

    Page :402-413

    Alexander Braun, M. Höfler, S. Auer

    Résumé Résumé Plan Plan   
  • ·Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer’s Disease

    Page :414-421

    A.C. Macedo, D.F.P.A. Durço, C. Tissot, J. Therriault, A.O. Vilela de Faria, É. Aumont, S. Servaes, N. Rahmouni, J. Fernandez-Arias, Y.-T. Wang, F.Z. Lussier, A. Bieger, E.R. Zimmer, T.A. Pascoal, S. Gauthier, Pedro Rosa-Neto

    Résumé Résumé Plan Plan   
  • ·Cytomegalovirus Infection and Alzheimer’s Disease: A Meta-Analysis

    Page :422-427

    Q. Ji, W. Lian, Y. Meng, W. Liu, M. Zhuang, N. Zheng, I.K. Karlsson, Yiqiang Zhan

    Résumé Résumé Plan Plan   
  • ·Nanolithium, a New Treatment Approach to Alzheimer’s Disease: A Review of Existing Evidence and Clinical Perspectives

    Page :428-434

    Solene Guilliot, E.N. Wilson, J. Touchon, M.E. Soto

    Résumé Résumé Plan Plan  

• Original Research

  • ·Personalized Computational Causal Modeling of the Alzheimer Disease Biomarker Cascade

    Page :435-444

    Jeffrey R. Petrella, J. Jiang, K. Sreeram, S. Dalziel, P.M. Doraiswamy, W. Hao, Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   

• Brief Communication

  • ·Fruit Intake and Alzheimer’s Disease: Results from Mendelian Randomization

    Page :445-452

    Wan-Zhe Liao, X.-F. Zhu, Q. Xin, Y.-T. Mo, L.-L. Wang, X.-P. He, Xu-Guang Guo

    Résumé Résumé Plan Plan   

• Original Research

  • ·Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions

    Page :453-462

    G. García-Lluch, Juan Pardo Albiach, L. Moreno, C. Peña-Bautista, M. Baquero, Consuelo Cháfer-Pericás

    Résumé Résumé Plan Plan   

• Brief Communication

  • ·The MAPP Room Memory Test: Examining Contextual Memory Using a Novel Computerized Test in Cognitively-Unimpaired Individuals with Autosomal Dominant Alzheimer’s Disease

    Page :463-468

    A. Giudicessi, P.A. Aduen, J.T. Fox-Fuller, J.E. Martinez, L.A. Gonzalez, C. Vila-Castelar, A. Baena, C. Pluim McDowell, A. Cronin-Golomb, F. Lopera, Yakeel T. Quiroz

    Résumé Résumé Plan Plan  

• Review

  • ·Beyond Vision: A View from Eye to Alzheimer’s Disease and Dementia

    Page :469-483

    C. Zheng, R. Zeng, G. Wu, Yijun Hu, Honghua Yu

    Résumé Résumé Plan Plan  

• Original Research

  • ·Higher Cognitive Reserve Is Beneficial for Cognitive Performance Via Various Locus Coeruleus Functional Pathways in the Pre-Dementia Stage of Alzheimer’s Disease

    Page :484-494

    Liang Gong, K. Chen, H. Zhang, S. Zhang, W. Luo, W. Zhou, B. Zhang, R. Xu, Chunhua Xi, Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   
  • ·Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer’s Disease

    Page :495-506

    F. Yang, N. Zhang, G.-Y. Ou, Shu-wen Xu

    Résumé Résumé Plan Plan   
  • ·The Impact of Testosterone on Alzheimer’s Disease Are Mediated by Lipid Metabolism and Obesity: A Mendelian Randomization Study

    Page :507-513

    L. Zhang, F. Yang, J. Ma, Y. Hu, M. Li, C. Wang, X. Chang, Lin Yang

    Résumé Résumé Plan Plan   
  • ·Unsupervised Online Paired Associates Learning Task from the Cambridge Neuropsychological Test Automated Battery (CANTAB®) in the Brain Health Registry

    Page :514-524

    Miriam T. Ashford, A. Aaronson, W. Kwang, J. Eichenbaum, S. Gummadi, C. Jin, N. Cashdollar, E. Thorp, E. Wragg, K.H. Zavitz, F. Cormack, T. Banh, J.M. Neuhaus, A. Ulbricht, M.R. Camacho, J. Fockler, D. Flenniken, D. Truran, R.S. Mackin, M.W. Weiner, R.L. Nosheny

    Résumé Résumé Plan Plan  

• Letter to the Editor

  • ·Alzheimer’s Disease-Associated APOE ε4 Frequencies in Indian Population Genomes May Suggest Implications in Lecanemab Treatment

    Page :525-526

    B. Jolly, Vinod Scaria

    Plan Plan   
  • ·Chronic Pain in Multiple Sites and Dementia: A Vicious Cycle?

    Page :527-528

    J. Tian, G. Jones, X. Lin, Y. Zhou, A. King, J. Vickers, Feng Pan

    Plan Plan